Activation of dendritic cells by local ablation of hepatocellular carcinoma
- 20 June 2005
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 43 (5), 817-822
- https://doi.org/10.1016/j.jhep.2005.04.016
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learningNature Medicine, 2003
- Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian CancerNew England Journal of Medicine, 2003
- Gene therapy for malignant liver diseaseExpert Opinion on Biological Therapy, 2002
- Cirrhotic Patients With or Without Hepatocellular Carcinoma Harbour AFP-Specific T-Lymphocytes That Can Be Activated in vitro by Human Alpha-FetoproteinScandinavian Journal of Gastroenterology, 2002
- Immunotherapy directed against α-fetoprotein results in autoimmune liver disease during liver regeneration in miceGastroenterology, 2001
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Mouse α-fetoprotein–specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in miceGastroenterology, 2000
- Natural adjuvants: Endogenous activators of dendritic cellsNature Medicine, 1999
- Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltrationHepatology, 1998
- Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinomaHepatology, 1998